Pharmaceutical

SyntheticGestalt and Enamine partner on AI drug discovery models

SyntheticGestalt and Enamine have announced a collaboration to develop a suite of AI models to aid in the discovery of drugs.

Jan 13, 2024 - 18:00
SyntheticGestalt and Enamine partner on AI drug discovery models
SyntheticGestalt and Enamine have announced a collaboration to develop a suite of AI models to aid in the discovery of drugs.
Read the original article

Tags:

Previous Article

Cereno partners with CordenPharma to scale up CS1 drug production

Next Article

Q&A: Exploring the challenges behind oncology trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Drug industry payments to eye docs boosted Medicare spending on pricier treatments

STAT+: Drug industry payments to eye docs boosted Medic...

Sep 28, 2023

Opinion: I’m an anesthesiologist. Kenneth Smith’s execution by nitrogen gas was far from ‘textbook’

Opinion: I’m an anesthesiologist. Kenneth Smith’s execu...

Jan 30, 2024

STAT+: Hospitals struggle to make money on CAR-T cancer therapies, but their fortunes may change

STAT+: Hospitals struggle to make money on CAR-T cancer...

Jul 20, 2023